As presented on December 6, 2024
Member Content
This webinar focuses on tailoring brachytherapy for intermediate risk prostate cancer patients, emphasizing micro boosting and safety evaluations. It discusses the multifocal nature of prostate cancer and recurrence sites after radiation. Insights from the FLAME trial highlight the benefits of focal boosting. A case study demonstrates brachytherapy's practical application, while various studies explore treatment duration and the impact of androgen deprivation therapy.
